⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Process Industries Converge in Houston for Inaugural ChemE Show 2026 Powered by ACHEMA
prnewswire.com
XOM
JNJ
LLY
LIN
FRO
APD
ETR
AA
PH
EcoVadis Joins European Commission's AI Act Advisory Forum to Shape Future of Responsible AI
prnewswire.com
JNJ
UL
JPM
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida
businesswire.com
JNJ
Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day
globenewswire.com
JNJ
ABT
New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma
globenewswire.com
JNJ
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma
prnewswire.com
JNJ
Patient Monitoring Devices Market worth $76.11 billion by 2031 | MarketsandMarkets™
prnewswire.com
MDT
ABT
DXCM
GEHC
BSX
MASI
BIIB
AMGN
GILD
BMY
MRK
PFE
JNJ
BAX
BOSC
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Announcement at EHA 2026
globenewswire.com
SNY
JNJ
Antibody Partnering Surges into 2026: Q1 Deals Top $36 Billion as Bispecifics and Discovery Platforms Drive Competition
globenewswire.com
ABBV
LLY
MRK
NVS
PFE
SNY
GILD
BMY
JNJ
UCB
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
businesswire.com
JNJ